Results for tag: "Caprelsa"

Caprelsa (vandetanib) is a drug used to treat medullary thyroid cancer (MTC). It is a kinase inhibitor, meaning it works by blocking certain proteins that help cancer cells grow and divide. Caprelsa is used in combination with other treatments, such as surgery and radiation therapy. It is also used to treat advanced MTC that has spread to other parts of the body. Caprelsa is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 2011. It is the only FDA-approved drug specifically for MTC. It is also approved in Europe and other countries. The Caprelsa market is a small but growing one. It is mainly composed of pharmaceutical companies that produce and market the drug. These companies are focused on providing effective treatments for MTC and other thyroid cancers. Some companies in the Caprelsa market include AstraZeneca, Merck, and Novartis. These companies are all involved in the research, development, and marketing of Caprelsa and other drugs for the treatment of thyroid cancer. Show Less Read more